MSCs from Amniotic Membrane

MSCs from Amniotic Membrane for Primary Immunodeficiency

How Stem Plus applies MSCs from Amniotic Membrane within a personalised Primary Immunodeficiency protocol — in the EU, from €3,000–€8,000.

For Primary Immunodeficiency, MSCs from Amniotic Membrane are selected for their specific regenerative profile and delivered under GMP conditions. The protocol combines cell type, dose and delivery route to match your individual assessment.

This is one of several cell options for Primary Immunodeficiency. Compare them on the Primary Immunodeficiency overview, or see the MSCs from Amniotic Membrane page.

Educational information; investigational for several conditions. Outcomes vary.

Compare stem-cell therapy by country, cost and evidence — in one place.

StemCellAtlas is your guide to stem-cell therapy: what the evidence shows, which conditions are treated, and the real all-in cost by country — typically €3,000–8,000 with our partner Stem Plus (Sofia), Europe's lowest-cost EU destination, versus $15,000–35,000 in the US.

Get an honest assessment